Highlights

  • Anteris Technologies Global Corp (ASX: AVR) closed at $11.55 on August 7, 2026.
  • The stock recorded an increase of approximately 5.19 percent for the session.
  • Shares traded within an intraday range of $10.81 to $11.56.
  • Market capitalisation stood at approximately $174.72 million.
  • Trading volume reached 14,907 shares during the session.

Anteris Technologies Global Corp (ASX: AVR) shares closed at $11.55 on August 7, 2026, after recording an increase of approximately 5.19 percent during the session. The stock traded close to its daily high of $11.56, while the broader S&P/ASX 200 Health Care Index ended lower after a decline during the trading day.

Anteris Technologies Share Price Movement on August 7, 2026

Anteris Technologies Global Corp shares recorded an increase of approximately 5.19 percent during the session. The stock traded between an intraday low of $10.81 and a high of $11.56 before closing at $11.55.

The daily movement reflected positive price activity during the session, with the closing price positioned near the day’s high. Share price movements can be influenced by company-specific developments, market participation, sector sentiment and broader market conditions.

Trading Volume and Market Capitalisation

Trading volume for Anteris Technologies Global Corp reached 14,907 shares during the session. Based on the closing share price, the company’s market capitalisation stood at approximately $174.72 million.

The trading activity provides an indication of market participation during the session, while the company’s market capitalisation places it among the smaller-capitalisation companies within the ASX health care sector.

One-Year Share Price Performance

Over the trailing one-year period, Anteris Technologies Global Corp recorded an increase of approximately 107.73 percent based on the data reviewed.

Biotechnology companies can experience notable share price movements over time due to company-specific developments, research progress, market expectations and changes in investor sentiment toward the sector.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) closed at 27,976.2 points on August 7, 2026, down 259.3 points or 0.92 percent.

The index recorded a day high of 28,235.5 points and a day low of 27,808.8 points, compared with a previous close of 28,235.5 points. Over the past 52 weeks, the index traded between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.44 percent.

Individual health care stocks can move differently from the broader index due to company-specific factors, trading activity and changes in investor participation.

About Anteris Technologies Global Corp

Anteris Technologies Global Corp is listed on the ASX under the ticker code AVR and operates within the health care sector.

Companies operating within biotechnology and medical technology segments can experience share price movements influenced by developments specific to their business, sector conditions and broader market trends.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Anteris Technologies Global Corp’s market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the session, while market capitalisation reflects the market value based on the reported share price and shares on issue. Daily share price movements represent activity over a specific trading period and do not necessarily indicate longer-term performance trends.

Conclusion

Anteris Technologies Global Corp (ASX: AVR) shares closed at $11.55 on August 7, 2026, after recording an increase of approximately 5.19 percent during the session. The stock traded within a range of $10.81 to $11.56, with trading volume of 14,907 shares and market capitalisation of approximately $174.72 million.

The broader S&P/ASX 200 Health Care Index closed lower at 27,976.2 points, down 0.92 percent. The reviewed data provides an overview of Anteris Technologies Global Corp’s share price activity and position within the ASX health care sector.